Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
The filoviruses Ebola virus and Marburg virus are among the most dangerous pathogens in the world. Both viruses cause viral hemorrhagic fever, with case fatality rates of up to 90%. Historically, filovirus outbreaks had been relatively small, with only a few hundred cases reported. However, the rece...
Saved in:
Main Authors: | John J. Suschak (Author), Connie S. Schmaljohn (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice
by: Callie E. Bounds, et al.
Published: (2017) -
Experimental Success in Marburg Virus Vaccination
by: Martyna Dydyk, et al.
Published: (2024) -
Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review.
by: Julii Brainard, et al.
Published: (2016) -
Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
by: Nanikaly Moyen, et al.
Published: (2015) -
Ebola vaccines in clinical trial: The promising candidates
by: Yuxiao Wang, et al.
Published: (2017)